SPRB Company Profile and Key Details

Q: Who are the executives of SPRB?

Dr. Libbie Mansell M.B.A., Ph.D.Chief Regulatory & Quality OfficerDr. Ralph William Charlton III, M.D.Chief Medical OfficerMs. P. J. RamtinSenior Vice President of Bus. OperationsDr. Mojtaba Noursalehi Ph.D.Senior Vice President of BiometricsDr. Javier Szwarcberg M.D., M.P.H.Chief Executive Officer & DirectorMr. Samir M. Gharib CPA, CPA, M.B.A.Pres & Chief Financial Officer

NASDAQ : SPRB

Spruce Biosciences

$59.37

2.09+3.65%

At Close 4:00 PM

58.74

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Spruce Biosciences, Inc. (SPRB) stock surged +3.65%, trading at $59.37 on NASDAQ, up from the previous close of $57.28. The stock opened at $57.73, fluctuating between $57.70 and $59.84 in the recent session.

Stock Snapshot

57.28

Prev. Close

81.46M

Market Cap

57.7

Day Low

-1.12

P/E Ratio

-52.87

EPS (TTM)

-0.81

Cash Flow per Share

57.73

Open

1.37M

Number of Shares

59.84

Day High

59.2%

Free Float in %

1.86

Book Value

44.8K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 04, 2026	56.51	59.84	56.51	59.37	45.68K
Apr 30, 2026	54.90	58.14	54.90	57.32	31.53K
Apr 29, 2026	54.90	57.36	54.33	55.52	47.1K
Apr 28, 2026	56.88	57.17	53.75	54.77	83.07K
Apr 27, 2026	56.09	58.29	55.38	57.18	108.97K
Apr 23, 2026	54.29	55.89	52.25	54.01	92.04K
Apr 22, 2026	56.75	56.75	52.01	52.36	184.94K
Apr 21, 2026	58.00	58.69	51.36	51.69	646.7K
Apr 20, 2026	70.61	70.68	67.67	69.90	36.82K
Apr 17, 2026	68.51	74.00	68.51	70.30	32.04K
Apr 16, 2026	68.89	70.95	66.66	67.90	19.37K
Apr 14, 2026	65.57	68.85	59.25	67.80	101.28K
Apr 13, 2026	63.24	68.48	61.98	64.51	62.44K
Apr 10, 2026	64.47	66.32	63.32	63.63	82.17K
Apr 09, 2026	63.50	68.00	63.50	66.01	83.9K
Apr 08, 2026	63.52	66.47	60.34	63.65	139.47K
Apr 07, 2026	63.65	64.49	58.39	62.15	61.24K
Apr 06, 2026	72.00	72.00	62.72	63.01	49.04K
Apr 02, 2026	69.53	71.56	67.50	70.50	37.54K
Apr 01, 2026	65.35	69.53	64.28	69.53	51.43K

Contact Details

Daly City, CA 94014

United States

https://www.sprucebiosciences.com 415 655 4168

About Company

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California.

Stock Peers

ARGX

27.59+3.52%

argenx SE$811.09 REGN

7.79+1.11%

Regeneron Pharmaceuticals, Inc.$709.21 UTHR

10.82+1.90%

United Therapeutics Corporation$581.22 MDGL

4.94002+0.96%

Madrigal Pharmaceuticals, Inc.$518.66 VRTX

5.93+1.40%

Vertex Pharmaceuticals Incorporated$429.85 PRAX

13.41+4.14%

Praxis Precision Medicines, Inc.$337.61 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.815+0.61%

Alnylam Pharmaceuticals, Inc.$297.93 KRYS

20.91+7.86%

Krystal Biotech, Inc.$286.95 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Spruce Biosciences, Inc. (SPRB) stock price?

Spruce Biosciences, Inc. (NASDAQ: SPRB) stock price is $59.37 in the last trading session. During the trading session, SPRB stock reached the peak price of $59.84 while $57.70 was the lowest point it dropped to. The percentage change in SPRB stock occurred in the recent session was 3.65% while the dollar amount for the price change in SPRB stock was $2.09.

SPRB's industry and sector of operation?

The NASDAQ listed SPRB is part of Biotechnology industry that operates in the broader Healthcare sector. Spruce Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SPRB?

Dr. Libbie Mansell M.B.A., Ph.D.
Chief Regulatory & Quality Officer
Dr. Ralph William Charlton III, M.D.
Chief Medical Officer
Ms. P. J. Ramtin
Senior Vice President of Bus. Operations
Dr. Mojtaba Noursalehi Ph.D.
Senior Vice President of Biometrics
Dr. Javier Szwarcberg M.D., M.P.H.
Chief Executive Officer & Director
Mr. Samir M. Gharib CPA, CPA, M.B.A.
Pres & Chief Financial Officer

How SPRB did perform over past 52-week?

SPRB's closing price is 748.14% higher than its 52-week low of $7.00 where as its distance from 52-week high of $838.13 is -92.92%.

How many employees does SPRB have?

Number of SPRB employees currently stands at 20.

Link for SPRB official website?

Official Website of SPRB is: https://www.sprucebiosciences.com

How do I contact SPRB?

SPRB could be contacted at phone 415 655 4168 and can also be accessed through its website. SPRB operates from 2001 Junipero Serra Boulevard, Daly City, CA 94014, United States.

How many shares of SPRB are traded daily?

SPRB stock volume for the day was 44.8K shares. The average number of SPRB shares traded daily for last 3 months was 64.91K.

What is the market cap of SPRB currently?

The market value of SPRB currently stands at $81.46M with its latest stock price at $59.37 and 1.37M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	20
Beta	3.82
Sales or Revenue	$10.09M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	20
Beta	3.82
Sales or Revenue	$10.09M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SPRB Company Profile and Key Details

Spruce Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways